Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
Open Access
- 26 July 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 6 (10), 2348-2355
- https://doi.org/10.1111/j.1600-6143.2006.01470.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-α-2b/ribavirinJournal of Hepatology, 2005
- Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantationJournal of Hepatology, 2005
- Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis CAmerican Journal of Transplantation, 2005
- Partial Splenic Embolization for the Treatment of Hypersplenism in Liver Transplanted Patients with Hepatitis C Virus Recurrence before peg-Interferon Plus RibavirinTransplantation, 2005
- Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver TransplantationAmerican Journal of Transplantation, 2005
- Fibrosis progression after liver transplantation in patients with recurrent hepatitis CJournal of Hepatology, 2004
- Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantationLiver Transplantation, 2004
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995